- ADC Therapeutics gewährt neuen Mitarbeitern Zuteilungen im Rahmen des Anreizplans
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
- ADC Therapeutics tritt demnächst den Indizes Russell 2000® und Russell 3000® bei
- ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
- ADC Therapeutics nimmt an der Jefferies Global Healthcare Conference teil
- ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
- ADC Therapeutics wird an der H.C. Wainwright 2nd Annual BioConnect Investor Conference an der NASDAQ teilnehmen
- ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
- ADC Therapeutics nimmt an der RBC Capital Markets Global Healthcare Conference 2024 teil
- ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
More ▼
Key statistics
On Friday, ADC Therapeutics SA (ADCT:NYQ) closed at 3.26, -46.03% below its 52-week high of 6.04, set on Feb 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.17 |
---|---|
High | 3.38 |
Low | 3.11 |
Bid | 3.14 |
Offer | 3.30 |
Previous close | 3.06 |
Average volume | 1.94m |
---|---|
Shares outstanding | 96.19m |
Free float | 75.90m |
P/E (TTM) | -- |
Market cap | 294.34m USD |
EPS (TTM) | -2.77 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:10 BST.
More ▼